Carbutamide

From Wikipedia, the free encyclopedia
Jump to navigation Jump to search
Carbutamide
Carbutamide.svg
Clinical data
AHFS/Drugs.comInternational Drug Names
Routes of
administration
Oral
ATC code
Identifiers
CAS Number
PubChem CID
ChemSpider
UNII
ChEMBL
CompTox Dashboard (EPA)
ECHA InfoCard100.005.841 Edit this at Wikidata
Chemical and physical data
FormulaC11H17N3O3S
Molar mass271.335 g/mol g·mol−1
3D model (JSmol)
 ☒N☑Y (what is this?)  (verify)

Carbutamide (brand name Glucidoral) is an anti-diabetic drug of the sulfonylurea class, developed by Servier.

It is classified as first-generation.[1]

It was patented in 1953 and approved for medical use in 1956.[2]

References[edit]

  1. ^ Ballagi-Pordány G, Köszeghy A, Koltai MZ, Aranyi Z, Pogátsa G (January 1990). "Divergent cardiac effects of the first and second generation hypoglycemic sulfonylurea compounds". Diabetes Res. Clin. Pract. 8 (2): 109–14. doi:10.1016/0168-8227(90)90020-T. PMID 2106423.
  2. ^ Fischer, Jnos; Ganellin, C. Robin (2006). Analogue-based Drug Discovery. John Wiley & Sons. p. 449. ISBN 9783527607495.